Nasdaq Biotechnology Ishares ETF (IBB)

$141.30 +1.07 (0.76%)
Market Cap N/A
Revenue (ttm) N/A
Net Income (ttm) N/A
EPS (ttm) N/A
PE Ratio N/A
Forward PE N/A
Profit Margin N/A
Debt to Equity Ratio N/A
Volume 552,023
Avg Vol N/A
Day's Range N/A - N/A
Shares Out N/A
Stochastic %K N/A
Beta N/A
Analysts N/A
Price Target N/A

Company Profile

The fund generally will invest at least 80% of its assets in the component securities of its underlying index and may invest up to 20% of its assets in certain futures, options and swap contracts, cash and cash equivalents. It is non-diversified.

Phone: 415-670-2000
BIOTECH_GURU
BIOTECH_GURU Aug. 13 at 3:17 AM
$XBI $IBB
0 · Reply
jewell69
jewell69 Aug. 12 at 10:42 PM
$LEGN re-entry did a b mkt on close today 8/12 08/12/2026 Buy LEGN LEGEND BIOTECH CORP FUNSPONSORED ADR 1 ADR REPS 2 ORD SHS 400 $20.65 -$8,260.00 More 04/14/2026 Sell LEGN LEGEND BIOTECH CORP FUNSPONSORED ADR 1 ADR REPS 2 ORD SHS 200 $18.46 $0.12 $3,691.88 More 04/13/2026 Buy LEGN LEGEND BIOTECH CORP FUNSPONSORED ADR 1 ADR REPS 2 ORD SHS 200 $17.685 -$3,537.00 at 1st glance, it looks like I am chasing it, but hidden within the numbers is a DOUBLE that it ended up G!V!NG !T BACK. the stock peaked at 36.18 on 6/2 (ahead of the tech doomsday 6/23, remember ) but this is biotech $IBB $XBI
0 · Reply
Woodman7
Woodman7 Aug. 12 at 1:58 AM
$CLNN $IBB $XBI $ARKG Further info on Clene presentation today:
0 · Reply
Woodman7
Woodman7 Aug. 12 at 1:38 AM
$CLNN $IBB $XBI $ARKG This is the perfect example of an “asymmetrical risk/reward” situation. The FDA has been essentially coaching CLNN management on how to best position their submission for accelerated approval. EVERYONE wants a breakthrough win in the fight against ALS. This may be it. I don’t see much downside risk at this price point even with a possible dilution towards the end of the year. IMHO, they have managed their funding needs tightly to date and have tried their best to minimize dilution effect on existing shareholders. Check out this write up. (Note: 2024= 2026 in attached)
1 · Reply
GettingBigNP
GettingBigNP Aug. 11 at 5:44 PM
$GNPX $XBI $IBB The more I dig, the more interesting this setup looks. ✅ ~500k post-split shares outstanding (per the reverse split adjustment) ✅ No meaningful debt ✅ Strong cash position - $27+ CASH/share ✅ Collaboration with Roche Diagnostics to advance biomarker validation in NSCLC ✅ Multiple clinical catalysts ahead Very likely we see double digits 10+ in the coming weeks, if not days 🚀
0 · Reply
Qumia
Qumia Aug. 11 at 3:08 PM
$SLS $XBI $IBB @Stocktwits Can This Be Pinned Again? Current Post Has Errors.
0 · Reply
Wildbil
Wildbil Aug. 11 at 2:27 PM
$IBB $SLS $XBI
0 · Reply
robcarroll
robcarroll Aug. 11 at 1:35 PM
$SLS The Pension Funds Are Showing Up At least seven U.S. public retirement systems, among the most conservative, mandate-bound investors in the market, now report positions in SELLAS. Four initiated this quarter, including the State Teachers Retirement System of Ohio. This isn't passive index funds adding; this is strict rules-based retirement funds getting overriding permission to add to a small-cap biotech. $XBI $IBB
12 · Reply
GettingBigNP
GettingBigNP Aug. 11 at 11:53 AM
$GNPX $XBI $IBB Hard to ignore the risk/reward here. ~$2M market cap for 2 FDA Phase 2 programs, 2 Fast Track designations, an Orphan Drug designation, multiple preclinical programs, ~$15M net cash and NO debt. Not to mention the Roche Diagnostics collaboration adding serious credibility to the biomarker strategy. The current valuation makes little sense on cash value alone, let alone the pipeline.
1 · Reply
GettingBigNP
GettingBigNP Aug. 10 at 10:39 PM
$TENX $XBI $IBB Folks, idk what the market is smoking 🤷🏻‍♂️ Phase 3 missed the primary endpoint, but TNX-103 showed a substantial benefit in a prespecified higher-disease-burden subgroup. Nearly $3/share in cash, no debt. Pretty sure MMs run this back toward $2 in the next few days. Feels like they just wanted to get max value from dip buyers/pre-data gamblers before letting it bounce the rest of this week. Long and strong here 🚀
1 · Reply
Latest News on IBB
These New Drugs Could Fuel Fresh Highs for Biotech and Pharma Stocks

Aug 7, 2026, 1:15 AM EDT - 6 days ago

These New Drugs Could Fuel Fresh Highs for Biotech and Pharma Stocks

IHE MRK MRNA PJP SMMT XBI

Nikkei 225, Kospi jolt Asian markets as AI rout and Fed fears collide

Jul 30, 2026, 12:28 AM EDT - 14 days ago

Nikkei 225, Kospi jolt Asian markets as AI rout and Fed fears collide

BBJP BIL BNO DBJP DBO DFJ DXJ

Kospi jumps 6% as Asia's battered semiconductor trade rebounds

Jul 22, 2026, 12:32 AM EDT - 22 days ago

Kospi jumps 6% as Asia's battered semiconductor trade rebounds

BBJP DBJP DFJ DXJ EWJ EWT EWY

U.S. Biotechs Are Keeping More Secrets to Beat Copycats in China

Jul 9, 2026, 10:00 PM EDT - 4 weeks ago

U.S. Biotechs Are Keeping More Secrets to Beat Copycats in China

XHB

3 Healthcare ETFs to Own in a Choppy Stock Market

Jul 6, 2026, 2:04 PM EDT - 5 weeks ago

3 Healthcare ETFs to Own in a Choppy Stock Market

XLV XPH

Market rotation is the most prevalent factor for healthcare outperformance, says Mizuho's Jared Holz

Jun 30, 2026, 4:25 PM EDT - 6 weeks ago

Market rotation is the most prevalent factor for healthcare outperformance, says Mizuho's Jared Holz

XBI XLV

Biotech ETFs Gain Momentum via AI Drug Discovery & Surging M&A

Jun 23, 2026, 4:34 PM EDT - 7 weeks ago

Biotech ETFs Gain Momentum via AI Drug Discovery & Surging M&A

BBH PBE SBIO XBI

BIO CEO says more consistency needed in FDA review process

Jun 23, 2026, 4:34 PM EDT - 7 weeks ago

BIO CEO says more consistency needed in FDA review process

BBH XHB

Biotech IPO window is opening but big pharma M&A still sets the pace, top bankers tell CNBC

Jun 16, 2026, 1:00 AM EDT - 2 months ago

Biotech IPO window is opening but big pharma M&A still sets the pace, top bankers tell CNBC

ARKG XBI GSK NUVL NVS

AV Laboratories, Founded by Pioneers of IVF Solutions, to Launch Fertility Clinic Program Featuring Its Award-Winning Skincare at ESHRE 2026 in London

May 21, 2026, 9:27 AM EDT - 2 months ago

AV Laboratories, Founded by Pioneers of IVF Solutions, to Launch Fertility Clinic Program Featuring Its Award-Winning Skincare at ESHRE 2026 in London

Biotech Investors Are Tuning Out the MAHA Chaos

May 20, 2026, 5:30 AM EDT - 3 months ago

Biotech Investors Are Tuning Out the MAHA Chaos

PJP XBI

Biotech Bloodbath Drags Health Care Down as MannKind and Soleno Stocks Sink

2026-02-27T18:27:37.000Z - 5 months ago

Biotech Bloodbath Drags Health Care Down as MannKind and Soleno Stocks Sink

MNKD SLNO XBI XLV

Funding for Risky Biotechs Is Returning

Jan 12, 2026, 12:00 PM EST - 7 months ago

Funding for Risky Biotechs Is Returning

XBI

Pharma stocks are set to take off this year, says UBS' Michael Yee

Jan 8, 2026, 11:01 AM EST - 7 months ago

Pharma stocks are set to take off this year, says UBS' Michael Yee

LLY VTYX

Mizuho's Jared Holz on what biotech dealmaking looks like in 2026

Dec 31, 2025, 2:27 PM EST - 8 months ago

Mizuho's Jared Holz on what biotech dealmaking looks like in 2026

XBI

This year's biotech laggards primed for 2026 recovery, says Goldman Sachs' Richter

Dec 19, 2025, 6:25 PM EST - 8 months ago

This year's biotech laggards primed for 2026 recovery, says Goldman Sachs' Richter

ALNY AMGN ARGX AZN

If M&A continues at this pace you want to be long Biotech into next year, says Mizuho's Jared Holz

Nov 14, 2025, 6:17 PM EST - 9 months ago

If M&A continues at this pace you want to be long Biotech into next year, says Mizuho's Jared Holz

CDTX MRK XBI XLV

'Fast Money' traders talk how to play biopharma space

Nov 11, 2025, 6:56 PM EST - 9 months ago

'Fast Money' traders talk how to play biopharma space

XLV

Biotech is back and a constructive place to put money to work, says Piper Sandler's Craig Johnson

Nov 11, 2025, 3:07 PM EST - 9 months ago

Biotech is back and a constructive place to put money to work, says Piper Sandler's Craig Johnson

XBI

Trade Tracker: Jason Snipe buys the IBB

Oct 17, 2025, 1:30 PM EDT - 10 months ago

Trade Tracker: Jason Snipe buys the IBB

‘Fast Money' traders talk opportunities in health care stocks

Oct 1, 2025, 5:48 PM EDT - 11 months ago

‘Fast Money' traders talk opportunities in health care stocks

AMGN BIIB BMY LLY MRK MRNA PFE

Real assets in biotech serving big markets the Street is finally noticing, says Mizuho's Jared Holz

Sep 3, 2025, 3:32 PM EDT - 1 year ago

Real assets in biotech serving big markets the Street is finally noticing, says Mizuho's Jared Holz

ARGX BBH BMRN CYTK XBI

Trump's deadline looms for Big Pharma companies facing new tariffs

Jul 16, 2025, 3:30 PM EDT - 1 year ago

Trump's deadline looms for Big Pharma companies facing new tariffs

XLV

Heard on the Street: Why pharma stocks have outperformed the broader market since Trump threatened the industry with a 200% tariff

Jul 13, 2025, 7:01 AM EDT - 1 year ago

Heard on the Street: Why pharma stocks have outperformed the broader market since Trump threatened the industry with a 200% tariff

XLV

Trump threatens 50% tariffs on copper, 200% on pharmaceuticals

Jul 9, 2025, 11:09 AM EDT - 1 year ago

Trump threatens 50% tariffs on copper, 200% on pharmaceuticals

CPER XBI

Fast Money: WTI, IBB, UBER, CAT

Jun 13, 2025, 6:20 PM EDT - 1 year ago

Fast Money: WTI, IBB, UBER, CAT

UBER CAT

Jefferies' Michael Yee: Drug discovery could be one of the biggest beneficiaries of generative AI

May 28, 2025, 12:22 PM EDT - 1 year ago

Jefferies' Michael Yee: Drug discovery could be one of the biggest beneficiaries of generative AI

AMGN BIIB DHR GILD ILMN NVS SDGR

Trump is right about drug prices. He's just going about it all wrong.

May 13, 2025, 1:43 PM EDT - 1 year ago

Trump is right about drug prices. He's just going about it all wrong.

XBI XLV

New vaccine chief rocks pharmaceutical stocks

May 7, 2025, 11:13 AM EDT - 1 year ago

New vaccine chief rocks pharmaceutical stocks

BNTX MRNA NVAX PFE GSK SRPT XBI

Trump Says Pharmaceutical Tariffs Coming in Near Future

Apr 14, 2025, 2:03 PM EDT - 1 year ago

Trump Says Pharmaceutical Tariffs Coming in Near Future

ABBV AMGN AZN BMY GSK JNJ LLY

Sell into strength in pharma, says Mizuho's Jared Holz

Apr 11, 2025, 7:17 PM EDT - 1 year ago

Sell into strength in pharma, says Mizuho's Jared Holz

XBI

Trump's pharmaceutical tariffs could raise costs for patients, worsen drug shortages

Apr 11, 2025, 10:30 AM EDT - 1 year ago

Trump's pharmaceutical tariffs could raise costs for patients, worsen drug shortages

ABBV AMGN AZN BMY GSK JNJ LLY

How to Play the Biotech Meltdown in the Age of RFK Jr. and Tariffs

Apr 11, 2025, 5:30 AM EDT - 1 year ago

How to Play the Biotech Meltdown in the Age of RFK Jr. and Tariffs

XBI

BMO's Siegerman talks the impact of tariffs on pharmaceutical stocks

Apr 9, 2025, 6:32 PM EDT - 1 year ago

BMO's Siegerman talks the impact of tariffs on pharmaceutical stocks

ABBV AMGN AZN BMY GSK JNJ LLY

Explainer: Prescription drugs become a target in Trump's trade war

Apr 9, 2025, 2:27 PM EDT - 1 year ago

Explainer: Prescription drugs become a target in Trump's trade war

ABBV AMGN AZN BMY GSK JNJ LLY

Healthy Returns: Trump says major pharmaceutical tariffs coming ‘very shortly'

Apr 9, 2025, 1:06 PM EDT - 1 year ago

Healthy Returns: Trump says major pharmaceutical tariffs coming ‘very shortly'

ABBV AMGN AZN BMY GSK JNJ LLY

Why drug stocks are no longer a safe haven from the stock market's turmoil

Apr 9, 2025, 11:49 AM EDT - 1 year ago

Why drug stocks are no longer a safe haven from the stock market's turmoil

ABBV AMGN BMY JNJ LLY MRK PFE

How tariffs could impact pharma and early-stage healthcare investments

Feb 3, 2025, 6:43 PM EST - 1 year ago

How tariffs could impact pharma and early-stage healthcare investments

XLV

Biotech walks a 'tightrope' amid unclear funding, regulations

Jan 30, 2025, 7:06 PM EST - 1 year ago

Biotech walks a 'tightrope' amid unclear funding, regulations

DCTH ELVN

Mizuho's Jared Holz on what Trump's FDA pick means for biotech innovation

Nov 25, 2024, 6:44 PM EST - 1 year ago

Mizuho's Jared Holz on what Trump's FDA pick means for biotech innovation

HIMS LLY MRNA NVO PFE

Health care stocks jump on Trump's nominee for FDA head

Nov 25, 2024, 6:22 PM EST - 1 year ago

Health care stocks jump on Trump's nominee for FDA head

HIMS LFMD MRNA PFE

Final Trade: Euro, IBB, SMH, NEM

Nov 20, 2024, 6:21 PM EST - 1 year ago

Final Trade: Euro, IBB, SMH, NEM

SMH NEM

Final Trade: West Pharma, Cameco, iShares Biotechnology ETF and Applied Digital Corp

Nov 15, 2024, 6:54 PM EST - 1 year ago

Final Trade: West Pharma, Cameco, iShares Biotechnology ETF and Applied Digital Corp

APLD CCJ WST

Biotech Stocks Are Showing Signs of Life. Why the Rally Could Continue.

Aug 30, 2024, 5:34 PM EDT - 2 years ago

Biotech Stocks Are Showing Signs of Life. Why the Rally Could Continue.

GILD XBI

Biotech stocks will get a tailwind from rate cuts, says Stempoint's Michelle Ross

Aug 12, 2024, 4:25 PM EDT - 2 years ago

Biotech stocks will get a tailwind from rate cuts, says Stempoint's Michelle Ross

LLY XBI

Analyst is 'extremely bullish' on biopharma

Jul 30, 2024, 3:25 PM EDT - 2 years ago

Analyst is 'extremely bullish' on biopharma

MRK PFE

This weight-loss ETF has performed well in its first five months. How does it compare with cheaper alternatives?

Apr 10, 2024, 9:27 AM EDT - 2 years ago

This weight-loss ETF has performed well in its first five months. How does it compare with cheaper alternatives?

AMGN ASND CYTK DXCM EW HRTS IHE

Biotech's Next Gold Rush: Weight-Loss Drugs

Apr 2, 2024, 4:56 PM EDT - 2 years ago

Biotech's Next Gold Rush: Weight-Loss Drugs

LLY NVO

BIOTECH_GURU
BIOTECH_GURU Aug. 13 at 3:17 AM
$XBI $IBB
0 · Reply
jewell69
jewell69 Aug. 12 at 10:42 PM
$LEGN re-entry did a b mkt on close today 8/12 08/12/2026 Buy LEGN LEGEND BIOTECH CORP FUNSPONSORED ADR 1 ADR REPS 2 ORD SHS 400 $20.65 -$8,260.00 More 04/14/2026 Sell LEGN LEGEND BIOTECH CORP FUNSPONSORED ADR 1 ADR REPS 2 ORD SHS 200 $18.46 $0.12 $3,691.88 More 04/13/2026 Buy LEGN LEGEND BIOTECH CORP FUNSPONSORED ADR 1 ADR REPS 2 ORD SHS 200 $17.685 -$3,537.00 at 1st glance, it looks like I am chasing it, but hidden within the numbers is a DOUBLE that it ended up G!V!NG !T BACK. the stock peaked at 36.18 on 6/2 (ahead of the tech doomsday 6/23, remember ) but this is biotech $IBB $XBI
0 · Reply
Woodman7
Woodman7 Aug. 12 at 1:58 AM
$CLNN $IBB $XBI $ARKG Further info on Clene presentation today:
0 · Reply
Woodman7
Woodman7 Aug. 12 at 1:38 AM
$CLNN $IBB $XBI $ARKG This is the perfect example of an “asymmetrical risk/reward” situation. The FDA has been essentially coaching CLNN management on how to best position their submission for accelerated approval. EVERYONE wants a breakthrough win in the fight against ALS. This may be it. I don’t see much downside risk at this price point even with a possible dilution towards the end of the year. IMHO, they have managed their funding needs tightly to date and have tried their best to minimize dilution effect on existing shareholders. Check out this write up. (Note: 2024= 2026 in attached)
1 · Reply
GettingBigNP
GettingBigNP Aug. 11 at 5:44 PM
$GNPX $XBI $IBB The more I dig, the more interesting this setup looks. ✅ ~500k post-split shares outstanding (per the reverse split adjustment) ✅ No meaningful debt ✅ Strong cash position - $27+ CASH/share ✅ Collaboration with Roche Diagnostics to advance biomarker validation in NSCLC ✅ Multiple clinical catalysts ahead Very likely we see double digits 10+ in the coming weeks, if not days 🚀
0 · Reply
Qumia
Qumia Aug. 11 at 3:08 PM
$SLS $XBI $IBB @Stocktwits Can This Be Pinned Again? Current Post Has Errors.
0 · Reply
Wildbil
Wildbil Aug. 11 at 2:27 PM
$IBB $SLS $XBI
0 · Reply
robcarroll
robcarroll Aug. 11 at 1:35 PM
$SLS The Pension Funds Are Showing Up At least seven U.S. public retirement systems, among the most conservative, mandate-bound investors in the market, now report positions in SELLAS. Four initiated this quarter, including the State Teachers Retirement System of Ohio. This isn't passive index funds adding; this is strict rules-based retirement funds getting overriding permission to add to a small-cap biotech. $XBI $IBB
12 · Reply
GettingBigNP
GettingBigNP Aug. 11 at 11:53 AM
$GNPX $XBI $IBB Hard to ignore the risk/reward here. ~$2M market cap for 2 FDA Phase 2 programs, 2 Fast Track designations, an Orphan Drug designation, multiple preclinical programs, ~$15M net cash and NO debt. Not to mention the Roche Diagnostics collaboration adding serious credibility to the biomarker strategy. The current valuation makes little sense on cash value alone, let alone the pipeline.
1 · Reply
GettingBigNP
GettingBigNP Aug. 10 at 10:39 PM
$TENX $XBI $IBB Folks, idk what the market is smoking 🤷🏻‍♂️ Phase 3 missed the primary endpoint, but TNX-103 showed a substantial benefit in a prespecified higher-disease-burden subgroup. Nearly $3/share in cash, no debt. Pretty sure MMs run this back toward $2 in the next few days. Feels like they just wanted to get max value from dip buyers/pre-data gamblers before letting it bounce the rest of this week. Long and strong here 🚀
1 · Reply
GettingBigNP
GettingBigNP Aug. 10 at 10:26 PM
$TENX $XBI $IBB The Phase 3 missed the primary endpoint, but the drug clearly showed benefit in a smaller subset of patients. Meanwhile, TENX has ~$3/share in cash and no debt. Feels like the market is pricing this for zero. I bought some shares down here.
0 · Reply
jjon2121
jjon2121 Aug. 10 at 6:53 PM
$LABD $LABU $XBI $BIB $IBB Two more small buyouts. Might not make bio pump hard at these prices. But might prevent any immediate selloff. Teledyne Technologies/Varex 1.1B https://www.bioworld.com/articles/733277-teledyne-expands-healthcare-portfolio-with-11b-varex-buy Jazz/Actio Biosciences 1.3B https://www.biopharmadive.com/news/jazz-actio-acquisition-deal-rare-neurological-epilepsy/827409/
1 · Reply
sethmarcus
sethmarcus Aug. 10 at 6:01 PM
Some of us are not surprised! $AMGN $CURE $IBB $UNH $XLV
1 · Reply
ETAlpha
ETAlpha Aug. 10 at 4:31 PM
$IBB is trading strong around $199.72 right now! The biotech index just cleared all major resistance into pure blue sky territory with limitless upside! True market pros don't fear new highs we ride relative strength leaders and capitalize on momentum! With explosive momentum locked in, avoid fighting the trend and scale into key support dips! Are you betting that this biotech powerhouse is about to shatter $200 and melt faces higher?check my profile for more live setups and charts.
0 · Reply
GettingBigNP
GettingBigNP Aug. 10 at 3:32 PM
$TENX $XBI $IBB
1 · Reply
GettingBigNP
GettingBigNP Aug. 9 at 9:46 PM
$GNPX $IBB $SPY $XBI
0 · Reply
robcarroll
robcarroll Aug. 8 at 10:17 PM
$IBB $SLS $SPY $XBI reposting for anyone that missed the exciting news yesterday.
1 · Reply
clan
clan Aug. 8 at 10:44 AM
$MNKD ❔️ The question is not, "What is Mannkind?" The answer to, "Who is Mannkind?" is ... It's a conglomerate of support networks, advocates, and partnerships, successfully working together to bring medical solutions to patients, young and old, so they may live life more humann. $IBB $MRK $AMGN
0 · Reply
GettingBigNP
GettingBigNP Aug. 7 at 8:14 PM
$MCRB $XBI $IBB Everything I’m posting is ultimately for the benefit of shareholders. I’m not expecting a post to change the stock overnight, but keeping shareholders informed, raising awareness, and holding management accountable certainly can’t hurt. Everyone can choose what they want to read or ignore.
0 · Reply
DarkH0rse91
DarkH0rse91 Aug. 7 at 6:43 PM
$IBB $SLS $SPY $XBI wrong. They are mandated to keep buying shares. It’s a nothing burger
2 · Reply
SellasgpsCurativeBAT11
SellasgpsCurativeBAT11 Aug. 7 at 6:38 PM
$IBB $SLS $SPY $XBI Absolutely Incredible considering the fact that Institutional Ownership in $SLS was under 10% at end of last year and is about to cross 50% after today’s Filings and that doesn’t include July/August 2026 numbers tracking 80% before BO PR! ✌️🙏❤️‍🩹
0 · Reply
robcarroll
robcarroll Aug. 7 at 6:22 PM
$SLS The Big Three Have Backed Up the Truck Vanguard, BlackRock and State Street — the world's three largest asset managers — now hold a combined 37.7 million shares of SELLAS, roughly 1 in 5 shares outstanding. This isn't normal $SPY $XBI $IBB index matching. This is targeted accumulation prior to a pivotal Phase 3 Regal Readout.
1 · Reply